HIMS · XBRL financial data
Hims & Hers Health financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (HIMS's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 227 | 247* | 278 | 316 | 402 | 481* | 586 | 545 | 599 | 618* | 608 | 753 |
| Cost of revenue | 39 | 43* | 49 | 59 | 84 | 112* | 155 | 129 | 157 | 173* | 211 | 272 |
| Gross profit | 187 | 204* | 229 | 257 | 318 | 370* | 431 | 416 | 442 | 444* | 397 | 481 |
| General and administrative | 36 | 32* | 35 | 41 | 45 | 48* | 49 | 67 | 81 | 76* | 110 | 165 |
| Total operating expenses | 196 | 204* | 219 | 246 | 296 | 351* | 373 | 389 | 430 | 435* | 475 | 578 |
| Operating income (loss) | (9) | (0)* | 10 | 11 | 22 | 19* | 58 | 27 | 12 | 9* | (78) | (97) |
| Other income (expense) | 2 | 3* | 3 | 2 | 1 | 4* | 3 | 6 | 8 | 6* | 4 | 4 |
| Income tax expense (benefit) | 1 | 1* | 1 | 0 | (52) | (4)* | 11 | (10) | (4) | (2)* | (9) | (6) |
| Net income (loss) | (8) | 1* | 11 | 13 | 76 | 26* | 49 | 43 | 16 | 21* | (92) | (86) |
| Earnings per share, basic USD per share | (0.04) | 0.01* | 0.05 | 0.06 | 0.35 | 0.12* | 0.22 | 0.19 | 0.07 | 0.09* | (0.40) | (0.37) |
| Earnings per share, diluted USD per share | (0.04) | 0.01* | 0.05 | 0.06 | 0.32 | 0.10* | 0.20 | 0.17 | 0.06 | 0.07* | (0.40) | (0.37) |
| Weighted average shares, basic millions of shares | 210 | 212* | 213 | 215 | 217 | 219* | 222 | 224 | 226 | 227* | 228 | 232 |
| Weighted average shares, diluted millions of shares | 210 | 212* | 229 | 235 | 235 | 248* | 247 | 257 | 249 | 281* | 228 | 232 |
Balance sheet
CSVFiscal quarters (HIMS's year ends in late December)
Cash flows
CSVFiscal quarters (HIMS's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (8) | 1* | 11 | 13 | 76 | 26* | 49 | 43 | 16 | 21* | (92) | (86) |
| Stock-based compensation | 17* | 18* | 19 | 24* | 25* | 24* | 25 | 36* | 40* | 34* | 37 | 42* |
| Depreciation and amortization | 2* | 3* | 3 | 4* | 4* | 6* | 8 | 10* | 18* | 18* | 22 | 29* |
| Net cash from operating activities | 25* | 22* | 26 | 54* | 85* | 86* | 109 | (19)* | 149* | 61* | 89 | (36)* |
| Net cash from investing activities | (31)* | 21* | 13 | (4)* | (10)* | (17)* | (33) | (21)* | (887)* | (84)* | (15) | 85* |
| Share repurchases | 0* | 2* | 28 | 20* | 30* | 5* | 0 | 0* | 9* | 80* | — | — |
| Net cash from financing activities | (2)* | (4)* | (30) | (25)* | (39)* | (14)* | (23) | 889* | (39)* | (98)* | (78) | 342* |
| Net change in cash | (7)* | 39* | 9 | 24* | 36* | 55* | 54 | 850* | (779)* | (117)* | (6) | 388* |
Compare with peers
SIC 8011 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 8011 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (8011) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Hims & Hers Health | 610 | 753 | (36)* | not reported | — | 10-QJun 30, 2026 |
| Teladoc Healthadded: same SIC | 850 | 605 | 106* | 182.3M | — | 10-QSep 30, 2026 |
| LifeMDadded: same SIC | 25 | 47 | (6.9)* | 48.2M | 3.6 quarters | 10-QJun 30, 2026 |
| Starling Oncologyadded: same SIC | 41 | 161 | 12* | 101.9M | — | 10-QJun 30, 2026 |
| Airsculpt Technologiesadded: same SIC | 19 | 43 | (1.2)* | 72.1M | 15.2 quarters | 10-QJun 30, 2026 |
| SBC Medical Group Holdingsadded: same SIC | 184 | 49 | 23* | 102.8M | — | 10-QJun 30, 2026 |
| Cardiff Lexingtonadded: same SIC | 0.2 | 2.2 | (0.7)* | 15.6M | 0.3 quarters | 10-QJun 30, 2026 |
| HealthLynkedadded: same SIC | 0 | not reported | (0.4)* | 3.0M | 0.0 quarters | 10-QJun 30, 2026 |
| Aunaadded: same SIC | 236 | year only | year only | not reported | — | 20-F/ADec 31, 2024 |
Not investment advice. Not affiliated with the U.S. SEC.